The interferon-gamma field trial: background, principles and progress
Vordermeier, M.; Goodchild, A.; Clifton-Hadley, R.; de la Rua, R.
Veterinary Record 155(2): 37-38
2004
ISSN/ISBN: 0042-4900 PMID: 15285281 Document Number: 568093
Since November 2002, the State Veterinary Service and the Veterinary Laboratories Agency have been conducting a field trial to assess the interferon-gamma test as an ancillary parallel test to the tuberculin skin test in herds with confirmed tuberculosis breakdowns. Here, Martin Vordermeier, Tony Goodchild, Richard Clifton-Hadley and Ricardo de la Rua describe the background to the trial, discuss the principle of the test and provide an update of progress so far.
Document emailed within 1 workday
Related Documents
Musch, E.; Högemann, B.; Gerritzen, A.; Fischer, H.P.; Wiese, M.; Kruis, W.; Malek, M.; Gugler, R.; Schmidt, G.; Huchzermeyer, H.; Gerlach, U.; Dengler, H.J.; Sauerbruch, T. 1998: Phase Ii clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B Hepato-Gastroenterology 45(24): 2282-2294Bang, A.T.; Bang, R.A. 2005: Background of the field trial of home-based neonatal care in Gadchiroli, India Journal of Perinatology: Official Journal of the California Perinatal Association 25 Suppl. 1: S3-10
Sypniewski, D.; Bednarek, I.; Gałka, S.; Loch, T.; Machnik, G. 2008: Influence of interferon-alpha and ribavirin on the transcription of interferon-gamma and IFN-gamma receptor genes in Jurkat cells Acta Poloniae Pharmaceutica 65(3): 345-351
Yamasaki, T.; Kagawa, T.; Takamura, M.; Moritake, K. 1995: Pharmacokinetics of intratumoral interferon-gamma activity following subcutaneous administration of recombinant interferon-gamma in a patient with metastatic brain tumor derived from renal cancer No Shinkei Geka. Neurological Surgery 23(2): 169-173
Kawakami, K.; Teruya, K.; Tohyama, M.; Kudeken, N.; Saito, A. 1994: A therapeutic trial of experimental tuberculosis with gamma-interferon in an immunocompromised mouse model Kekkaku: 69(10): 607-613
Hunzelmann, N.; Anders, S.; Fierlbeck, G.; Hein, R.; Herrmann, K.; Albrecht, M.; Bell, S.; Thur, J.; Muche, R.; Adelmann-Grill, B.; Wehner-Caroli, J.; Gaus, W.; Krieg, T. 1997: Systemic scleroderma. Multicenter trial of 1 year of treatment with recombinant interferon gamma Archives of Dermatology 133(5): 609-613
Kawata, N.; Takimoto, Y.; Hirakata, H.; Fuse, T.; Hirano, D.; Yamanaka, Y. 1994: Clinical trial of inhalant recombinant interferon-gamma in patients with pulmonary metastasis from renal tumor (preliminary report) Hinyokika Kiyo. Acta Urologica Japonica 40(9): 773-776
Nemunaitis, J.; Bohart, C.; Fong, T.; Meyer, W.; Edelman, G.; Paulson, R.S.; Orr, D.; Jain, V.; O'Brien, J.; Kuhn, J.; Kowal, K.J.; Burkeholder, S.; Bruce, J.; Ognoskie, N.; Wynne, D.; Martineau, D.; Ando, D. 1998: Phase I trial of retroviral vector-mediated interferon (IFN)-gamma gene transfer into autologous tumor cells in patients with metastatic melanoma Cancer Gene Therapy 5(5): 292-300
Karim, A.M.; Guichon, D.; Yihun, B.Y.; Zemichael, N.F.; Lorenzana, K.; Barofsky, J.; Betemariam, W. 2019: Application of behavioral economics principles to reduce injectable contraceptive discontinuation in rural Ethiopia: a stratified-pair, cluster-randomized field trial Gates Open Research 3: 1494
Günther, G.; Otto, B. 1993: Interferon. An overview of the state of basic research with special regard to interferon-gamma Arzneimittel-Forschung 43(2): 182-188
Russo, D.; Fanin, R.; Zuffa, E.; Damiani, D.; Gallizia, C.; Michieli, M.; Testoni, N.; Benfenati, D.; Visani, G.; Zaccaria, A. 1990: Sequential treatment of Ph-positive chronic myeloid leukemia with interferon gamma and interferon alpha Haematologica 75(4): 334-339
Rubin, B.Y.; Bartal, A.H.; Anderson, S.L.; Millet, S.K.; Hirshaut, Y.; Feit, C. 1983: The anticellular and protein-inducing activities of human gamma interferon preparations are mediated by the interferon Journal of Immunology 130(3): 1019-1020
Margolick, J.B.; Ambrus, J.L.; Volkman, D.J.; Fauci, A.S. 1986: Human T4+ lymphocytes produce a phagocytosis-inducing factor (PIF) distinct from interferon-alpha and interferon-gamma Journal of Immunology 136(2): 546-554
Koyama, S.; Narita, M. 1988: In vitro effects of interferon-alpha and interferon-gamma on hematopoietic progenitor cells in bone marrow Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 51(8): 1540-1549
Sayers, T.J.; Wiltrout, T.A.; McCormick, K.; Husted, C.; Wiltrout, R.H. 1990: Antitumor effects of alpha-interferon and gamma-interferon on a murine renal cancer (Renca) in vitro and in vivo Cancer Research 50(17): 5414-5420
Grigorian, S.S.; Pritsker, A.D.; Onufrieva, E.K.; Chireshkin, D.G.; Ershov, F.I. 1991: The effect of exogenous interferon on the in vitro production of alpha- and gamma-interferon by the lymphocytes of patients with respiratory papillomatosis Voprosy Virusologii 36(5): 407-409
Sabbah, A.; Kerdranvat, H.; Lauret, M.G. 1993: Measurement of interferon gamma (gamma IFN) and interleukin 4 (IL4) in asthma and atopic dermatitis Allergie et Immunologie 25(10): 408
Song, S-Hun.; Lee, J-Kwan.; Lee, N-Woo.; Saw, H-Suk.; Kang, J-Sung.; Lee, K-Wan. 2008: Interferon-gamma (IFN-gamma): a possible prognostic marker for clearance of high-risk human papillomavirus (HPV) Gynecologic Oncology 108(3): 543-548
Gustafsson, A.; Sundström, S.; Lundgren, E. 1986: The augmentation of human natural killer cell activity by interferon-gamma is not associated with the induction of the interferon-alpha-inducible proteins Journal of Immunology 137(1): 167-171
Colpaert, S.; Vastraelen, K.; Liu, Z.; Maerten, P.; Shen, C.; Penninckx, F.; Geboes, K.; Rutgeerts, P.; Ceuppens, J.L. 2002: In vitro analysis of interferon gamma (IFN-gamma) and interleukin-12 (IL-12) production and their effects in ileal Crohn's disease European Cytokine Network 13(4): 431-437